{"id":"W2117505171","doi":"10.1111/dom.12187","title":"Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years","year":2013,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":295,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba","funders":"Astellas Pharma; AstraZeneca","keywords":"Dapagliflozin; Medicine; Placebo; Insulin; Adverse effect; Diabetes mellitus; Type 2 diabetes; Population; Internal medicine; Urology; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001483641,0.0002005478,0.0005502186,0.0001924891,0.00004017127,0.00003159417,0.00006086034,0.00007747144,0.00009080605],"category_scores_gemma":[0.00007891865,0.0001561757,0.00003028897,0.0002709777,0.0001217452,0.0002418032,0.0001044303,0.0001123483,0.00001035193],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001654028,"about_ca_system_score_gemma":0.00001509651,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008529334,"about_ca_topic_score_gemma":0.00000755892,"domain_scores_codex":[0.9988744,0.00004610426,0.0002476509,0.0002937776,0.000209179,0.0003288985],"domain_scores_gemma":[0.9993647,0.00009585668,0.00009465194,0.0002271961,0.00008415367,0.0001333876],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00006236294,0.0005148385,0.9637934,0.0001339084,0.0001964252,9.226417e-7,0.0001754159,0.000001507962,0.0003365041,0.0001805988,0.0001260553,0.03447808],"study_design_scores_gemma":[0.005962978,0.0002912765,0.9907804,0.0001967149,0.0002724728,2.774191e-8,0.00001687689,0.00001678509,0.0007380617,0.0001237372,0.001435336,0.0001653519],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964898,0.002314785,3.490119e-7,0.00007424539,0.0001074356,0.0007443573,0.00001208591,0.00002914574,0.0002278493],"genre_scores_gemma":[0.9984123,0.0005751522,0.0005100074,0.0002382584,0.00003776668,0.00002001021,0.00006375415,0.00002113846,0.0001216626],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03431273,"threshold_uncertainty_score":0.6368662,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.004339992995139996,"score_gpt":0.1913791158533762,"score_spread":0.1870391228582363,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}